Henshaw Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Henshaw Capital’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,200	Closed	-$229K	–	292
2023 Q4	$229K	Hold	1,200	–	–	0.01%	268
2023 Q3	$239K	Buy	1,200 +185	+18%	+$43.8K	0.01%	256
2023 Q2	$290K	Sell	1,015 -901	-47%	-$250K	0.02%	193
2023 Q1	$415K	Hold	1,916	–	–	0.03%	141
2022 Q4	$394K	Sell	1,916 -384	-17%	-$97.1K	0.03%	140
2022 Q3	$640K	Hold	2,300	–	–	0.05%	124
2022 Q2	$440K	Hold	2,300	–	–	0.03%	158
2022 Q1	$477K	Hold	2,300	–	–	0.03%	164
2021 Q4	$410K	Hold	2,300	–	–	0.02%	199
2021 Q3	$474K	Sell	2,300 -534	-19%	-$105K	0.03%	169
2021 Q2	$538K	Hold	2,834	–	–	0.03%	164
2021 Q1	$369K	Hold	2,834	–	–	0.02%	219
2020 Q4	$294K	Buy	+2,834	New	+$245K	0.02%	260

Other funds holding SWAV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Henshaw Capital's SWAV Position: Q1 2024 in Review

Henshaw Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,200 shares — an estimated $229K sold.

Henshaw Capital first reported a position in SWAV in Q4 2020 and held it in 13 quarters. The position peaked at $640K in Q3 2022. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

Henshaw Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Henshaw Capital sold 1,200 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $229K.
Henshaw Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
Henshaw Capital's Shockwave Medical, Inc. Common Stock position peaked at $640K in Q3 2022.
488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Henshaw Capital's 13F filing for Q1 2024, filed 28 May 2026.